Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;4(10):e70039.
doi: 10.1002/cpz1.70039.

Synthesis of N3-Methyluridine- and 2'-O-Alkyl/2'-Fluoro-N3-Methyluridine-Modified Phosphoramidites and Their Incorporation into DNA and RNA Oligonucleotides

Avijit Sahoo  1 , Kiran R Gore  1
Affiliations

Synthesis of N3-Methyluridine- and 2'-O-Alkyl/2'-Fluoro-N3-Methyluridine-Modified Phosphoramidites and Their Incorporation into DNA and RNA Oligonucleotides

Avijit Sahoo et al. Curr Protoc. 2024 Oct.

Abstract

In this article, we describe the synthesis of N3-methyluridine (m3U) and 2'-O-alkyl/2'-fluoro-N3-methyluridine (2'-O-alkyl/2'-F-m3U) phosphoramidites as well as their incorporation into a 14-mer DNA and RNA oligonucleotide sequence. Synthesis of the 2'-O-alkyl-m3U phosphoramidite starts with commercially available uridine to achieve a tritylated m3U intermediate, followed by 2'-O-alkylation and finally phosphitylation. Synthesis of the 2'-F-m3U phosphoramidite is obtained from a commercially available 2'-F-uridine nucleoside. These phosphoramidite monomers are compatible with DNA and RNA oligonucleotide synthesis using conventional phosphoramidite chemistry. This strategy offers efficient synthetic access to various modifications at the 2'-position of m3U that can be employed in numerous nucleic acid-based therapeutic applications, including antisense technologies, small interfering RNAs, CRISPR-Cas9, and aptamers. The data presented in this article are based on our previously published reports. © 2024 Wiley Periodicals LLC. Basic Protocol 1: Synthesis of 2'-O-alkyl-N3-methyluridine analogs and their corresponding phosphoramidites Alternate Protocol 1: Synthesis of 2'-O-TBDMS-N3-methyluridine and its phosphoramidite Alternate Protocol 2: Synthesis of 2'-fluoro-N3-methyluridine and its phosphoramidite Basic Protocol 2: Solid-phase synthesis of N3-methyluridine-modified DNA and RNA oligonucleotides.

Keywords: N3‐methyluridine; RNA modification; modified oligonucleotide; phosphoramidite; solid‐phase synthesis.

PubMed Disclaimer

References

Literature Cited

    1. Barbieri, I., & Kouzarides, T. (2020). Role of RNA modifications in cancer. Nature Reviews Cancer, 20(6), 303‐322. https://doi.org/10.1038/s41568‐020‐0253‐2
    1. Chiu, Y. L., & Rana, T. M. (2003). siRNA function in RNAi: A chemical modification analysis. RNA, 9(9), 1034‐1048. https://doi.org/10.1261/rna.5103703
    1. Das, G., Harikrishna, S., & Gore, K. R. (2022). Influence of sugar modifications on the nucleoside conformation and oligonucleotide stability: A critical review. The Chemical Record, 22(12), e202200174. https://doi.org/10.1002/tcr.202200174
    1. Desrosiers, R., Friderici, K., & Rottman, F. (1974). Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proceedings of the National Academy of Sciences of the United States of America, 71(10), 3971‐3975. https://doi.org/10.1073/pnas.71.10.397
    1. Egli, M., & Manoharan, M. (2023). Chemistry, structure and function of approved oligonucleotide therapeutics. Nucleic Acids Research, 51(6), 2529‐2573. https://doi.org/10.1093/nar/gkad067

MeSH terms

LinkOut - more resources